ASTEC LIFESCIENCES LTD (ASTEC) financials

ASTEC LIFESCIENCES LTD (ASTEC) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

The Company is into manufacturing of agrochemical active ingredients (technical), bulk and formulations, intermediate products and it sells its products in India as well as exports them to approximately 24 countries.Astec also has undertaken a number of custom synthesis projects, for its clients in Europe, Japan and the US. It is present only in business to business sale (B2B).[1][2][3]

Market Cap: ₹1,583Cr.
Current Price: ₹710
ROE: -25.3%
ROCE: -5.46%
Book Value: ₹175
Dividend Yield: 0.00%
52W High / Low: ₹942/512

In Jun 2026, ASTEC LIFESCIENCES LTD (ASTEC) reported sales ₹84 Cr and net profit ₹-19 Cr.

Annual TTM: sales ₹441 Cr, net profit ₹-67 Cr.

Shareholding: Promoters 71.97% (Sep 2026), FIIs 0.02% (Sep 2026), DIIs 3.34% (Sep 2026), Public 24.67% (Sep 2026), No. of Shareholders 19,707% (Sep 2026).

ASTEC quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	99	94	120	91	74	125	159	84
Expenses	118	100	114	102	80	121	149	84
Operating Profit	-20	-6	6	-11	-7	4	9	-1
OPM %	-20%	-6%	4.6%	-12%	-9%	3.2%	6%	-0.8%
Other Income	2	2	1	0	1	-1	3	1
Interest	9	10	10	11	8	7	8	8
Depreciation	11	11	12	12	10	11	12	11
Profit before tax	-39	-25	-16	-33	-24	-16	-8	-19
Tax %	-0%	60%	3%	-0%	-0%	-0%	-2%	-0%
Net Profit	-39	-40	-16	-33	-24	-16	-8	-19
EPS in Rs	-17.22	-18.04	-7.19	-14.76	-10.97	-7.06	-3.49	-8.41
Raw PDF	—	—	—	—	—	—	—	—

ASTEC profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	522	555	677	628	458	381	448	441
Expenses	437	443	522	551	464	447	453	435
Operating Profit	85	112	154	77	-6	-66	-4	6
OPM %	16%	20%	23%	12%	-1.3%	-17%	-1.0%	1.3%
Other Income	12	8	10	13	5	6	3	3
Interest	13	5	9	21	25	37	35	31
Depreciation	23	26	34	34	36	44	45	45
Profit before tax	61	89	121	35	-62	-141	-81	-67
Tax %	23%	27%	26%	27%	-24%	-4%	-0%	—
Net Profit	47	65	90	26	-47	-135	-81	-67
EPS in Rs	21.19	28.88	40.10	11.39	-20.98	-60.18	-36.36	-29.93
Dividend Payout %	6%	5%	3%	12%	-0%	-0%	-0%	—

ASTEC balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	20	20	20	20	20	20	20	22
Reserves	183	227	289	376	399	349	214	368
Borrowings	176	99	188	280	341	494	555	449
Other Liabilities	83	227	182	221	219	111	92	102
Total Liabilities	461	572	678	897	979	974	880	941
Fixed Assets	167	194	213	340	318	386	499	459
CWIP	19	24	116	23	127	165	21	20
Investments	0	0	0	0	0	0	0	0
Other Assets	275	354	349	534	533	423	360	462
Total Assets	461	572	678	897	979	974	880	941

ASTEC cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	15	169	-8	23	74	10	-8	-81
Cash from Investing Activity	-52	-74	-73	-104	-112	-135	-15	-4
Cash from Financing Activity	37	-95	81	80	38	125	24	94
Net Cash Flow	-0	0	0	0	-0	-0	0	9
Free Cash Flow	-37	123	-111	-80	-42	-125	-24	-85
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	42%	219%	13%	34%	103%	-208%	20%	1,802%

ASTEC shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	66.74%	70.87%	70.87%	72.42%	71.97%	71.97%	71.97%	71.97%
FIIs	1.20%	0.25%	0.02%	0.00%	0.04%	0.03%	0.01%	0.02%
DIIs	5.40%	4.34%	4.26%	4.01%	3.17%	3.33%	3.33%	3.34%
Public	26.64%	24.53%	24.84%	23.57%	24.82%	24.67%	24.69%	24.67%
No. of Shareholders	19,057	18,689	18,549	18,276	22,293	21,041	19,889	19,707

ASTEC key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	103	112	123	148	90	135	141	202
Inventory Days	121	131	113	176	268	224	196	169
Days Payable	83	219	137	180	161	102	100	107
Cash Conversion Cycle	141	24	99	145	197	256	237	263
Working Capital Days	-2	8	4	12	-17	-1	-26	-56
ROCE %	20%	20%	22%	22%	8%	-4%	-13%	-5%

ASTECUpdated 18 Oct 2026, 17:11

Astec Lifesciences Ltd

ASTECUpdated 18 Oct 2026, 17:11

Market Cap

₹1,583Cr.

Current Price

₹710

High / Low

₹942/512

ROE-25.3%

ROCE-5.46%

Book Value₹175

Face Value₹10.0

Dividend Yield0.00%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	143	6	140	2	9	-11	-26	-8	-3.67
Sep 2023	111	6	114	1	9	-18	-24	-13	-6
Dec 2023	51	6	69	1	9	-32	-24	-24	-10.87
Mar 2024	154	7	141	2	9	-1	3	-1	-0.44
Jun 2024	69	7	116	1	9	-62	-36	-40	-17.74
Sep 2024	99	9	118	2	11	-39	0	-39	-17.22
Dec 2024	94	10	100	2	11	-25	60	-40	-18.04
Mar 2025	120	10	114	1	12	-16	3	-16	-7.19
Jun 2025	91	11	102	0	12	-33	0	-33	-14.76
Sep 2025	74	8	80	1	10	-24	0	-24	-10.97
Dec 2025	125	7	121	-1	11	-16	0	-16	-7.06
Mar 2026	159	8	149	3	12	-8	-2	-8	-3.49
Jun 2026	84	8	84	1	11	-19	0	-19	-8.41

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	252	12	200	-15	12	12	-18	15	6.65
Mar 2016	221	12	190	0	10	8	95	0	0.16
Mar 2017	298	12	236	-8	14	29	33	19	8.56
Mar 2018	368	11	299	12	15	56	37	35	15.68
Mar 2019	431	12	354	11	19	56	36	36	16
Mar 2020	522	13	437	12	23	61	23	47	21.19
Mar 2021	555	5	443	8	26	89	27	65	28.88
Mar 2022	677	9	522	10	34	121	26	90	40.1
Mar 2023	628	21	551	13	34	35	27	26	11.39
Mar 2024	458	25	464	5	36	-62	-24	-47	-20.98
Mar 2025	381	37	447	6	44	-141	-4	-135	-60.18
Mar 2026	448	35	453	3	45	-81	0	-81	-36.36
TTM	441	31	435	3	45	-67	—	-67	-29.93

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	71.97%
FIIs	0.02%
DIIs	3.34%
Public	24.67%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public
Dec 2023	66.75%	1.28%	9.74%	—	22.22%
Mar 2024	66.75%	1.25%	7.88%	—	24.12%
Jun 2024	66.75%	1.03%	3.37%	—	28.85%
Sep 2024	66.74%	0.53%	4.5%	—	28.2%
Dec 2024	66.74%	1.2%	5.4%	—	26.64%
Mar 2025	70.87%	0.25%	4.34%	—	24.53%
Jun 2025	70.87%	0.02%	4.26%	—	24.84%
Sep 2025	72.42%	0%	4.01%	—	23.57%
Dec 2025	71.97%	0.04%	3.17%	—	24.82%
Mar 2026	71.97%	0.03%	3.33%	—	24.67%
Jun 2026	71.97%	0.01%	3.33%	—	24.69%
Sep 2026	71.97%	0.02%	3.34%	—	24.67%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	19	117	93	128	358	127	12	1	217	358
Mar 2016	19	99	127	84	329	94	20	0	214	329
Mar 2017	20	118	127	69	334	103	8	0	223	334
Mar 2018	20	150	125	119	413	115	42	0	256	413
Mar 2019	20	183	176	83	461	167	19	0	275	461
Mar 2020	20	227	99	227	572	194	24	0	354	572
Mar 2021	20	289	188	182	678	213	116	0	349	678
Mar 2022	20	376	280	221	897	340	23	0	534	897
Mar 2023	20	399	341	219	979	318	127	0	533	979
Mar 2024	20	349	494	111	974	386	165	0	423	974
Mar 2025	20	214	555	92	880	499	21	0	360	880
Mar 2026	22	368	449	102	941	459	20	0	462	941

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	3	-14	11	0
Mar 2016	3	-16	15	2
Mar 2017	19	-18	-1	1
Mar 2018	65	-49	-18	-2
Mar 2019	15	-52	37	0
Mar 2020	169	-74	-95	0
Mar 2021	-8	-73	81	0
Mar 2022	23	-104	80	0
Mar 2023	74	-112	38	0
Mar 2024	10	-135	125	0
Mar 2025	-8	-15	24	0
Mar 2026	-81	-4	94	9

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	143	132	136	122	103	112	123	148	90	135	141	202
Inventory Days	143	186	133	122	121	131	113	176	268	224	196	169
Days Payable	181	179	117	156	83	219	137	180	161	102	100	107
Cash Conversion Cycle	105	140	152	88	141	24	99	145	197	256	237	263
Working Capital Days	17	-29	0	-8	-2	8	4	12	-17	-1	-26	-56
ROCE %	20%	10%	20%	22%	20%	20%	22%	22%	8%	-4%	-13%	-5%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ASTEC LIFESCIENCES LTD (ASTEC)?

The reported market capitalisation for ASTEC LIFESCIENCES LTD (ASTEC) is ₹1,583Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of ASTEC?

The current price shown for ASTEC LIFESCIENCES LTD (ASTEC) on Fincrux is ₹710 with a 52-week high/low of ₹942/512.

What were ASTEC latest quarterly results?

For Jun 2026, ASTEC LIFESCIENCES LTD (ASTEC) reported sales ₹84 Cr and net profit ₹-19 Cr (figures in ₹ crore unless noted).

What are ASTEC annual sales and net profit?

For TTM, ASTEC LIFESCIENCES LTD (ASTEC) shows sales of ₹441 Cr and net profit of ₹-67 Cr on the Fincrux profit & loss statement.

Who owns ASTEC LIFESCIENCES LTD (ASTEC)?

Latest shareholding for ASTEC LIFESCIENCES LTD (ASTEC) on Fincrux: Promoters 71.97% (Sep 2026), FIIs 0.02% (Sep 2026), DIIs 3.34% (Sep 2026), Public 24.67% (Sep 2026), No. of Shareholders 19,707% (Sep 2026).

Where can I find ASTEC LIFESCIENCES LTD (ASTEC) financials?

ASTEC LIFESCIENCES LTD (ASTEC) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show ASTEC balance sheet and cash flow?

Yes. The ASTEC LIFESCIENCES LTD (ASTEC) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 17:11